Skip to main content
Signal8
Parikh Shamik J profile photo

Shamik J. Parikh

CIK: 0001916853

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Humacyte, Inc. logo
HUMA

Humacyte, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    May 18, 2026
    Sale(S)
    Direct
    45.9K shares at avg. $0.90$41K
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 16, 2025
    Award(A)
    Direct
    311.1K shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Apr 10, 2025
    Purchase(P)
    Direct
    7.5K shares at avg. $1.55$12K
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jan 21, 2025
    Award(A)

    Stock Options (right to buy)

    Direct
    283.1K shares-

1-4 of 4

About Parikh Shamik J

Parikh Shamik J (SEC CIK 0001916853) files insider reports with the SEC as Chief Medical Officer of Humacyte, Inc. (HUMA).

Signal8 holds 4 ownership filings by Parikh Shamik J, all Form 4s, filed between Jan 23, 2025 and May 20, 2026. Those filings report 4 transactions, from Jan 21, 2025 to May 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Parikh Shamik J's filings is in DURHAM, NC.

Recent filings by Parikh Shamik J

  • May 18, 2026: Open-market sale of HUMA shares (Form 4, code S).
  • Nov 16, 2025: Grant or award of HUMA shares (Form 4, code A).
  • Apr 10, 2025: Open-market purchase of HUMA shares (Form 4, code P).
  • Jan 21, 2025: Grant or award of HUMA derivative securities (Form 4, code A).

Other insiders filing for Humacyte, Inc. (HUMA)

How to read Form 4 transaction codes